$WGS News

Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $74

What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%

Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $63

Hedge Funder Eli Casdin Is Loading up on GeneDx Shares

GeneDx Holdings (WGS) Valuation After Q1 2026 Earnings Miss Guidance Cut And Legal Scrutiny

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?

A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation

GeneDx (WGS) Fell Despite Continued Execution Improvement

GeneDx: The 50% Crash Creates A Compelling Entry

Why Is GeneDx Stock Surging Thursday?

GeneDx Holdings Corp. 2026 Q1 - Results - Earnings Call Presentation

The 'Alarming' Results That Caused GeneDx Stock To Plummet 49%

Canaccord Genuity Maintains Buy on GeneDx Holdings, Lowers Price Target to $75

Does GeneDx’s Guidance Cut And Core Shift Reshape The Bull Case For GeneDx Holdings (WGS)?

Wells Fargo Maintains Overweight on GeneDx Holdings, Lowers Price Target to $75

Guggenheim Maintains Buy on GeneDx Holdings, Lowers Price Target to $70

BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $90

GeneDx Holdings Corp. Q1 2026 Earnings Call Summary

GeneDx Q1 Earnings Call Highlights